Boothbay Fund Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1364 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1453 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1520 |
|
|
2024
Q1 | – | Sell |
-23,749
| Closed | -$39.4K | – | 1511 |
|
|
2023
Q4 | $39.4K | Buy |
+23,749
| New | +$39.4K | ﹤0.01% | 1379 |
|
|
2021
Q3 | – | Sell |
-10,965
| Closed | -$35K | – | 1754 |
|
|
2021
Q2 | $35K | Buy |
+10,965
| New | +$35K | ﹤0.01% | 1621 |
|
|
2019
Q2 | – | Sell |
-15,333
| Closed | -$78K | – | 687 |
|
|
2019
Q1 | $78K | Sell |
15,333
-15,229
| -50% | -$77.5K | 0.01% | 571 |
|
|
2018
Q4 | $105K | Buy |
+30,562
| New | +$105K | 0.02% | 476 |
|
|
2016
Q3 | – | Sell |
-18,850
| Closed | -$28K | – | 661 |
|
|
2016
Q2 | $28K | Hold |
18,850
| – | – | 0.01% | 457 |
|
|
2016
Q1 | $27K | Buy |
18,850
+6,180
| +49% | +$8.85K | 0.02% | 238 |
|
|
2015
Q4 | $21K | Buy |
+12,670
| New | +$21K | 0.01% | 505 |
|